Scott M. Robertson
CIK: 0001882035
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Bicara Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 9, 2026BCAX
Bicara Therapeutics Inc.
Award(A)DirectStock Option (Right to Buy)
19.5K shares- - Jun 9, 2025BCAX
Bicara Therapeutics Inc.
Award(A)DirectStock Option (Right to Buy)
23.7K shares- - Sep 12, 2024BCAX
Bicara Therapeutics Inc.
Award(A)DirectStock Option (Right to Buy)
23.7K shares-
1-3 of 3 transactions
About Robertson Scott M.
Robertson Scott M. (SEC CIK 0001882035) files insider reports with the SEC as Director of Bicara Therapeutics Inc. (BCAX).
Signal8 holds 4 ownership filings by Robertson Scott M. (1 Form 3, 3 Form 4), filed between Sep 12, 2024 and Jun 10, 2026. Those filings report 3 transactions, from Sep 12, 2024 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Robertson Scott M.'s filings is in BOSTON, MA.
Recent filings by Robertson Scott M.
Other insiders filing for Bicara Therapeutics Inc. (BCAX)
- Cohlhepp Ryan, President, COO & Interim CEO
- Larson Jennifer, Chief Financial Officer
- Hyep Ivan, Chief Financial Officer
- Mazumdar Claire, Chief Executive Officer
- Bender Jeremy, Director
- Oliger Christy J., Director